Skip to content

Immediate KMC neurodevelopmental follow-up study.

The follow-up study to evaluate the impact of continuous KMC initiated immediately after birth compared to KMC initiated after stabilization in newborns with birth weight 1.0 to less then 1.8 kg on their neurodevelopmental outcomes in low-resource settings.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021899
Enrollment
3000
Registered
2019-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: immediate KMC: iKMC (continuous skin-to-skin contact/ kangaroo mother care initiated immediately after birth with mother or surrogate) Control Intervention1: KMC after stabilisation: KM

Sponsors

World Health Organization
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All babies born alive in the participating hospitals, with birth weight between 1.0 to less then 1.8 kg, enrolled in parent study & survive the first 28 days of life are eligible for participation in this trial with their mothers. The mother-baby pair is still eligible if the mode of delivery is caesarean section, if the babies are twins or if the mother experiences some complications during labour and delivery that are expected to resolve within 3 days.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria (parent study) (i) the mother is younger than 15 years of age (ii) the mother (or her guardian in case mother is a minor aged 15-17 years) is unable or unwilling to provide consent; (iii) the mother is unlikely to be able to provide KMC for the first 3 days after birth, e.g. she has eclampsia, shock or has undergone major surgery; (iv) the baby is unable to breathe spontaneously within 1 hour of birth; (v) multiple pregnancy: triplets or more; (vi) the baby has a congenital malformation that interferes with the intervention, or the intervention interferes with the required care for the congenital malformation; (vii) the place of residence is not a part of the defined study area (the study area will be defined to make 28-day follow up home visit feasible) (viii) If for any reason the mother baby pair cannot be enrolled within 2 hours of birth of the baby. 2. Exclusion criteria (current study) (i) The mother or guardian is unwilling to provide the consent. (ii)The mother infant duo are unwilling to come for follow-up visits. (iii)

Design outcomes

Primary

MeasureTime frame
I. Developmental delay II. Cerebral palsy III. Hearing impairment IV. Vision impairment V. EpilepsyTimepoint: I. Between 24 to 30 month chronological age. II. 6,12 and 24 month III. before 3 Month IV. 12 month V. 3,6,9,12,15,18,21,24 month

Secondary

MeasureTime frame
Feeding practicesTimepoint: 3,6,9,12,15,18,21,24 month;GrowthTimepoint: at 6,12 and 24 months of age;Home environmentTimepoint: 18 months;Maternal depressionTimepoint: 6 and 12 months of age;MortalityTimepoint: between 3 months of age and 2 years of age

Countries

Ghana, India, Malawi, Nigeria, Tanzania

Contacts

Public ContactDr Nitya Wadhwa

Vardhman Mahavir Medical College & Safdarjung Hospital

sehgal_rachna@hotmail.com9818376378

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026